5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.73▼ | 1.74▼ | 1.74▼ | 1.75▼ | 2.42▼ |
MA10 | 1.72▲ | 1.74▼ | 1.74▼ | 1.95▼ | 3.00▼ |
MA20 | 1.73▼ | 1.73▼ | 1.74▼ | 2.45▼ | 3.10▼ |
MA50 | 1.74▼ | 1.76▼ | 1.83▼ | 3.07▼ | 6.58▼ |
MA100 | 1.73▼ | 1.86▼ | 2.17▼ | 3.22▼ | 14.05▼ |
MA200 | 1.76▼ | 2.24▼ | 2.76▼ | 5.95▼ | 38.46▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.000▲ | 0.001▲ | 0.009▲ | -0.061▼ | 0.111▲ |
RSI | 45.888▼ | 45.569▼ | 42.736▼ | 24.122▼ | 30.671▼ |
STOCH | 55.833 | 36.485 | 51.315 | 10.039▼ | 22.943 |
WILL %R | -60.000 | -81.250▼ | -46.429 | -92.987▼ | -96.453▼ |
CCI | -34.470 | -115.709▼ | 8.088 | -86.334 | -177.108▼ |
Wednesday, March 19, 2025 10:24 PM
Agenus (NASDAQ:AGEN – Get Free Report)‘s stock had its “neutral” rating reissued by stock analysts at HC Wainwright in a research report issued on Tuesday,Benzinga reports. Separately, Robert W. Baird ...
|
Wednesday, March 19, 2025 04:31 AM
Agenus Inc. ("Agenus" or the "Company") (Nasdaq: AGEN), an immuno-oncology company focused on innovation, today announced the results of its national Colorectal Cancer in Focus survey, highlighting ...
|
Saturday, March 15, 2025 05:00 PM
Agenus Inc. (NASDAQ:AGEN – Free Report) – Investment analysts at William Blair boosted their Q1 2025 earnings per share (EPS) estimates for Agenus in a research report issued to clients and ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
19/03/25 | 1.76 | 1.79 | 1.71 | 1.73 | 450,327 |
18/03/25 | 1.73 | 1.792 | 1.641 | 1.73 | 573,227 |
17/03/25 | 1.89 | 1.93 | 1.73 | 1.78 | 519,610 |
14/03/25 | 1.68 | 1.91 | 1.6508 | 1.86 | 940,421 |
13/03/25 | 1.86 | 1.94 | 1.67 | 1.675 | 589,553 |
12/03/25 | 2.10 | 2.10 | 1.855 | 1.865 | 438,960 |
11/03/25 | 2.29 | 2.29 | 1.93 | 2.05 | 749,676 |
10/03/25 | 2.34 | 2.375 | 2.13 | 2.15 | 385,707 |
07/03/25 | 2.37 | 2.42 | 2.33 | 2.35 | 290,626 |
06/03/25 | 2.39 | 2.41 | 2.31 | 2.35 | 292,177 |
|
|
||||
|
|
||||
|
|